500 College Road East
Suite 310
Princeton, NJ 08540
United States
609 683 1880
https://www.agiletherapeutics.com
Sector(s):
Industry:
Full Time Employees: 19
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Alfred F. Altomari | Chairman, President & CEO | 594.62k | N/A | 1959 |
Mr. Scott M. Coiante | CFO, Senior VP & Treasurer | 401.83k | N/A | 1967 |
Mr. Geoffrey P. Gilmore | Senior VP & Chief Administrative Officer | 455.12k | N/A | 1966 |
Dr. Paul Korner M.B.A., M.D. | Senior VP & Chief Medical Officer | 454.88k | N/A | 1966 |
Mr. Robert G. Conway M.E. | Senior VP and Chief Corporate Planning & Supply Chain Officer | 408.45k | N/A | 1957 |
Ms. Amy Welsh | Senior VP & Chief Commercial Officer | N/A | N/A | 1971 |
Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Agile Therapeutics, Inc.’s ISS Governance QualityScore as of May 1, 2024 is 8. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 8; Compensation: 8.